Aidoc and Imbio team up on AI for pulmonary embolism
Artificial intelligence (AI) software developers Aidoc and Imbio have formed...Read more on AuntMinnie.comRelated Reading:
New AI lab at UMass focuses on thoracic imaging
Siemens adds Imbio AI apps to syngo.via platform
FDA clears Aidoc's incidental PE AI algorithm
Imbio teams up with Genentech for AI in lung disease
Aidoc secures European contract
FDA OKs use of Aidoc AI software for COVID-19 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 8, 2020 Category: Radiology Source Type: news
RSNA awards Margulis prize to COVID-19 paper
The RSNA has awarded its Alexander R. Margulis Award for Scientific Excellence...Read more on AuntMinnie.comRelated Reading:
RSNA announces pulmonary embolism challenge winners
RSNA names PE as 2020 AI challenge topic
RSNA unveils plans for virtual technical exhibition
RSNA addresses COVID-19 impact on private practice
RSNA wins grant to develop learning center in Africa (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 29, 2020 Category: Radiology Source Type: news
RSNA announces pulmonary embolism challenge winners
RSNA in collaboration with the Society for Thoracic Radiology (STR) has announced...Read more on AuntMinnie.comRelated Reading:
COVID-19, AI, and dose reduction top RSNA's CT agenda
How to work the virtual RSNA conference
AI shows growing maturity in RSNA informatics sessions
RSNA names PE as 2020 AI challenge topic
ACR to develop COVID-19 imaging research registry (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 23, 2020 Category: Radiology Source Type: news
Rates of VTE, Major Bleeding High in Primary CNS Lymphoma
Pulmonary embolism and major bleeding linked to increased mortality risk (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 20, 2020 Category: Cancer & Oncology Tags: Neurology, Oncology, Pharmacy, Pulmonology, Radiology, Journal, Source Type: news
Penumbra Announces Partnership with RapidAI to Enable Faster Clinical Decision-Making for Pulmonary Embolism
ALAMEDA, Calif., Nov. 10, 2020 -- (Healthcare Sales & Marketing Network) -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced a new partnership to develop solutions to enable faster clinical decision-... Devices Penumbra Inc, RapidAI, pulmonary embolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 10, 2020 Category: Pharmaceuticals Source Type: news
New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need for data in ...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutaneous for...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
Clots in COVID-19 Tied to Illness Severity, Not Virus Itself Clots in COVID-19 Tied to Illness Severity, Not Virus Itself
COVID-19 does not independently increase the risk of pulmonary embolism (PE), new findings suggest.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 5, 2020 Category: Intensive Care Tags: Cardiology News Source Type: news
Majority Of Hospitalized Coronavirus Patients Left With Heart Abnormalities, Study Finds
cbsoptanon.onScriptsReady(function(cmp){cmp.ot.targetingAllowed(function(a){if(a) AnvatoPlayer("p1").init({"mcp":"cbs","width":"100%","height":"100%","video":"4821234","autoplay":false,"titleVisible":false,"accessKey":"EZqvRyKE7qmqDflDPXIw6U7kKZEA0Vx7","accessControl":{"preview":false},"pInstance":"p1","plugins":{"heartbeat":{"account":"cbslocal-global-unified","publisherId":"cbslocal","jobId":"sc_va","marketingCloudId":"823BA0335567497F7F000101@AdobeOrg","trackingServer":"cbsdigitalmedia.hb.omtrdc.net","customTrackingServer":"cbsdigitalmedia.d1.sc.omtrdc.net","chapterTracking":false,"version":"1.5"},"comscore":{"clientId"...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 26, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Covid-19 Boston, MA Health Syndicated CBSN Boston Syndicated Local Coronavirus Dr. Mallika Marshall Source Type: news
Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revascularization, a c...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news
DVT Screening, Early Treatment, Prevent PE in Necrotizing Pancreatitis DVT Screening, Early Treatment, Prevent PE in Necrotizing Pancreatitis
Ultrasound screening enabled identification and early treatment of extremity deep vein thrombosis (DVT), thereby preventing symptomatic pulmonary embolism (PE) in a single center trial.Reuters Health Information (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - October 23, 2020 Category: Gastroenterology Tags: General Surgery News Source Type: news
Imaging analysis AI startups announce 510(k)s for prostate cancer, incidental pulmonary embolism algorithms
Quantib and Ezra ' s automated tools support diagnosis and measurement of the prostate and prostate lesions, while Aidoc ' s algorithm acts as an always-on catch net for unsuspected blockage of pulmonary arteries. (Source: mobihealthnews)
Source: mobihealthnews - October 21, 2020 Category: Information Technology Source Type: news
The Most Important Things To Know About Blood Clots
Blood clots are responsible for one in four deaths globally if you include heart attacks and strokes, but people working from home may be at higher risk for pulmonary embolism too. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - October 14, 2020 Category: Pharmaceuticals Authors: Tara Haelle, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation business pharma Source Type: news
Pulmonary artery thrombosis a complication of radiation therapy
(American Roentgen Ray Society) According to ARRS' American Journal of Roentgenology, the imaging findings of in situ pulmonary artery thrombosis (PAT) associated with radiation therapy (RT) are different from those of acute pulmonary emboli and do not appear to embolize. Due to the differences in clinical prognosis and subsequent management strategies, in situ PAT associated with RT -- which has not previously been described in the English literature -- must be distinguished from pulmonary embolism. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 9, 2020 Category: Cancer & Oncology Source Type: news
When Loved One Is in ICU, Spouse Sees Health Risks
Compared to others, those with a spouse in the ICU had increased odds of an event such as chest pain, heart attack, stroke, irregular heart rhythm, heart failure or a blood clot in the lungs (pulmonary embolism) within a month. (Source: WebMD Health)
Source: WebMD Health - October 5, 2020 Category: Consumer Health News Source Type: news
